Karnataka: Basavaraj Bommai urges CM to revoke order suspending Jan Aushadhi Kendras
In a letter addressing the issue, he stated that the association of Jan Aushadhi Kendra owners from Haveri district has appealed for the revocation of the state government's order to suspend these kendras.
According to the release, Bommai noted that suspending the Jan Aushadhi Kendras operating in government hospital premises would obstruct the central government's objective of providing high-quality generic medicines to the standard and economically weaker sections of society at low and affordable prices.
The government must review and give appropriate instructions to the concerned authorities to take necessary action immediately.
https://x.com/BelladArvind/status/1925464485512585723
In his X post, Deputy Leader of Opposition Arvind Bellad criticised Karnataka Health Minister Dinesh Gundu Rao, alleging a deliberate sidelining of 'Jan Aushadhi Kendra' in government hospitals.
Bellad claimed that 190 of 410 essential medicines are out of stock in state hospitals, with a procurement process taking at least 45 days, severely impacting North Karnataka hospitals. He accused the government of forcing poor patients to buy costly branded drugs by removing affordable generics from Jan Aushadhi Kendras.
Bellad further alleged that the move is a setup for mass procurement contracts, enabling kickbacks and opaque deals, leading to substandard medicines, contaminated IV fluids, and avoidable deaths in Ballari, Hubballi, and Belagavi.
He termed it a 'healthcare scam' and accused the Congress-led government of exploiting the poor for profit.
Earlier, Health Minister Dinesh Gundo in his X post on Wednesday, said, 'There are 1400 Jan Aushada Kendras in Karnataka and only around 180 are in our Govt facilities. Our clear policy is that the poor people who come to our hospitals will get medicine free of cost, and there's no need for them to pay for it.' (ANI)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
3 hours ago
- News18
Genetic evidence confirms early puberty accelerates ageing, disease: Study
Washington, DC [US], August 22 (ANI): Researchers discovered that early puberty or childbirth doubles women's risk for major diseases and accelerates ageing, while later timing offers protective benefits. Genetic analysis reveals evolutionary tradeoffs, where reproductive advantages early in life create health burdens later. Reproductive timing matters when it comes to ageing and age-related a study now online at eLife,, Buck researchers determine that girls who go through puberty (the onset of menstruation) before the age of 11 or women who give birth before the age of 21 have double the risk of developing type 2 diabetes, heart failure and obesity and quadruple the risk of developing severe metabolic study also reveals that later puberty and childbirth are genetically associated with longer lifespan, lower frailty, slower epigenetic ageing and reduced risk of age-related diseases, including type 2 diabetes and Alzheimer' Professor Pankaj Kapahi, PhD, senior author of the study, says the public health implications of the research are significant.'Even though women are routinely asked about their menstrual and childbirth history when they receive medical care, this information has rarely factored into the care they receive outside of OB/GYN," said Pankaj Kapahi. 'These risk factors, whether positive or negative, clearly have a significant influence on a variety of age-related diseases and should be considered in the larger context of overall health," added Pankaj. The research was based on one of the most comprehensive analyses to date, using regression analysis on nearly 200,000 women in the UK Biobank to confirm genetic associations.'We identified 126 genetic markers that mediate the effects of early puberty and childbirth on ageing," said postdoctoral fellow Yifan Xiang, MD, who led the research.'Many of these markers are involved in well-known longevity pathways, such as IGF-1, growth hormone, AMPK and mTOR signalling, key regulators of metabolism and ageing," added Yifan Xiang. While updated research guidelines call for the use of both sexes in preclinical research in mice, Kapahi says this current study still challenges traditional experimental design, noting that most disease models use virgin female mice, which may not accurately represent real-world ageing patterns.'If evolution has shaped us to prioritise early reproduction at the cost of ageing, how can we leverage this knowledge to extend healthspan in modern society? Kapahi asks.'While we cannot change our genetic inheritance, understanding these genetic tradeoffs empowers us to make informed choices about health, lifestyle and medical care," added Kapahi. The study also identifies several genetic pathways that can be manipulated to optimise health for mothers as well as their offspring. Other Buck researchers involved in the study include: Vineeta Tanwar, Parminder Singh, and Lizellen La Follette. (ANI)
Economic Times
12 hours ago
- Economic Times
Expand AYUSH-based services to promote integrative oncology approaches: Parliamentary panel
ANI Representational image. A parliamentary committee has recommended taking proactive steps to expand the institutional footprint of AYUSH-based healthcare services across the country to promote integrative oncology approaches and enable patients to benefit from diverse therapeutic options rooted in India's traditional knowledge systems for combating cancer. Headed by Narain Dass Gupta, the Committee on Petitions of the Rajya Sabha noted in its 163rd report presented on Wednesday that the penetration of alternative systems of medicine -- namely Ayurveda, Homeopathy, Unani and Siddha -- within the domain of cancer care remains significantly limited in comparison to allopathic treatment modalities. The Ministry of AYUSH has reported ongoing advancements in cancer-related research across these traditional systems. It also recommended the establishment of dedicated institutions for AYUSH-based cancer care in every state and Union Territory (UT), modelled on the All India Institute of Ayurveda, New Delhi. "Such a move would broaden access, promote integrative oncology approaches and enable patients to benefit from diverse therapeutic options rooted in India's traditional knowledge systems," the panel said. The Committee further recommended that cancer be declared a notifiable disease across all states and UTs. It said reliable data is vital for assessing public health issues, particularly cancer, where comprehensive information is essential to track trends, design policies and plan infrastructure. At present, cancer data is primarily drawn from the National Cancer Registry Programme (NCRP), which covers only about 18 per cent of the population, which is insufficient for a national picture. Healthcare professionals have long advocated for declaring cancer a notifiable disease. At present, the government's position is guided by WHO norms, which limit notification to communicable diseases. "However, given the rising cancer burden in India, this stance warrants a serious reconsideration. Given India's rising cancer burden, the Committee is of the view that declaring cancer notifiable would ensure systematic reporting, generate real-time and credible data, strengthen surveillance and enable evidence-based policymaking. "It would support targeted interventions, rational resource allocation, region-specific strategies and development of appropriate infrastructure," it said in the report. While some states have already made cancer notifiable, a national mandate would ensure uniform documentation and a clear picture of the disease burden. The Committee also noted that while banks, PSUs and corporates invest substantially in corporate social responsibility (CSR) largely in healthcare, education and women's empowerment, these efforts are often compliance-driven and concentrated around operational areas. It, therefore, recommended that a defined share of CSR funds be earmarked for cancer care to complement government efforts, particularly by establishing diagnostic centres, radiotherapy units and palliative care facilities in underserved and rural regions. Corporates should realign CSR strategies with national health priorities, shifting to a needs-based outcome-driven model that meaningfully addresses gaps in the cancer care ecosystem and contributes to inclusive nation-building, the panel said. Patient Assistance Programmes are a commendable initiative by the government aimed at ensuring access to affordable medicines, particularly for economically vulnerable sections of society, the panel noted. Programmes such as the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) play a critical role in providing low-cost medicines to patients from low-income groups. It noted that while some pharmaceutical companies do offer patient support programmes, their presence remains limited. It recommended engaging more pharmaceutical manufacturers to implement such initiatives, particularly in areas where access to healthcare services is inadequate. "This would greatly enhance the accessibility and affordability of essential treatments for disadvantaged populations. The Patient Assistance Programmes must also educate the patients about the treatment methodologies available and ensure that they adhere to the treatment plan. "They should also be educated about the different government schemes available," the panel recommended.
Time of India
13 hours ago
- Time of India
US health officials urge Kennedy to stop spreading vaccine misinformation
Washington: Hundreds of current and former employees of US health agencies on Wednesday accused President Donald Trump's health secretary of putting them at risk by spreading false information. In an open letter, the federal officials criticized Secretary Robert F. Kennedy Jr. -- a noted vaccine skeptic -- nearly two weeks after an armed attack on the headquarters of the Centers for Disease Control and Prevention (CDC), the main US health agency. A gunman who blamed the Covid-19 vaccine for sickening him targeted several buildings at the Atlanta-based CDC on August 8, killing a police officer. The attack "was not random," the signees of the open letter said, pointing to "growing mistrust in public institutions, driven by politicized rhetoric that has turned public health professionals from trusted experts into targets of villainization -- and now, violence." Kennedy, who has repeatedly aired false information about vaccines and slammed the agencies he heads as corrupt, was accused of fueling the mistrust. Kennedy "is complicit in dismantling America's public health infrastructure and endangering the nation's health by repeatedly spreading inaccurate health information," the open letter said, imploring the health chief to change his stance. Since taking office, the nephew of assassinated president John F. Kennedy has made numerous pronouncements that run counter to scientific consensus, particularly about vaccines. This shift toward vaccine skepticism has been denounced by many experts. A petition calling on Congress to impeach Kennedy had gathered more than 12,600 signatures as of Wednesday. The latest open letter from US civil servants, many of whom signed anonymously, comes on the heels of other similar texts backed by federal employees denouncing actions of the Trump administration. Taking such a step was not without risk: nearly 140 staffers at the Environmental Protection Agency who spoke out publicly were placed on leave in last month.
